4
8. 1. 2026.
GLP-1 receptor agonists and reduced dementia risk: Real-world evidence stacks up.
GLP-1 receptor agonists and reduced dementia risk: Real-world evidence stacks up.
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više